Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004

Journal of Clinical Microbiology

Volumn 46, Issue 1, 2008, Pages 79-86

  Luca Harari, Bogdan ^a   Ekelund, Kim ^b,d   Van Der Linden, Mark ^c   Staum Kaltoft, Margit ^b   Hammerum, Anette M ^b   Jasir, Aftab ^a  

^a LUND UNIVERSITY   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EXOTOXIN; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN; SUPERANTIGEN; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CEREBROSPINAL FLUID; DENMARK; EMM GENE; ENDEMIC DISEASE; EPIDEMIC; FATALITY; GENE IDENTIFICATION; HUMAN; INCIDENCE; JOINT; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; SPEA GENE; SPEC GENE; SPEG GENE; SSA GENE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD; CARRIER PROTEINS; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; DENMARK; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENDEMIC DISEASES; FASCIITIS, NECROTIZING; FEMALE; GENES, BACTERIAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JOINTS; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; SEROTYPING; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

SPEA; STREPTOCOCCUS PYOGENES;

EID: 38149141425     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01626-07     Document Type: Article

References (60)

1. Aarestrup, F. M., Y. Agerso, P. Gerner-Smidt, M. Madsen, and L. B. Jensen. 2000. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn. Microbiol. Infect. Dis. 37:127-137.
2. Beres, S. B., G. L. Sylva, D. E. Sturdevant, C. N. Granville, M. Liu, S. M. Ricklefs, A. R. Whitney, L. D. Parkins, N. P. Hoe, G. J. Adams, D. E. Low, F. R. DeLeo, A. McGeer, and J. M. Musser. 2004. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. USA 101:11833-11838.
3. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3:191-200.
4. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694.
5. Cleary, P., D. Johnson, and L. Wannamaker. 1979. Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift. J. Infect. Dis. 140:747-757.
6. Cleary, P. P., E. L. Kaplan, J. P. Handley, A. Wlazlo, M. H. Kim, A. R. Hauser, and P. M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339:518-521.
7. Colman, G., A. Tanna, A. Efstratiou, and E. T. Gaworzewska. 1993. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J. Med. Microbiol. 39:165-178.
8. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, R. Fontana, et al. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
9. Daneman, N., A. McGeer, D. E. Low, G. Tyrrell, A. E. Simor, M. McArthur, B. Schwartz, P. Jessamine, R. Croxford, and K. A. Green. 2005. Hospital-acquired invasive group A streptococcal infections in Ontario, Canada, 1992-2000. Clin. Infect. Dis. 41:334-342.
10. Darenberg, J., B. Luca-Harari, A. Jasir, A. Sandgren, H. Pettersson, C. Schalen, M. Norgren, V. Romanus, A. Norrby-Teglund, and B. H. Normark. 2007. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45:450-458.
11. Davies, H. D., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, D. E. Low, et al. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335:547-554.
12. De Azavedo, J. C., R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
13. Demers, B., A. E. Simor, H. Vellend, P. M. Schlievert, S. Byrne, F. Jamieson, S. Walmsley, and D. E. Low. 1993. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 16:792-802.
14. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45(Suppl.):3-12.
15. Ekelund, K., J. Darenberg, A. Norrby-Teglund, S. Hoffmann, D. Bang, P. Skinhoj, and H. B. Konradsen. 2005. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J. Clin. Microbiol. 43:3101-3109.
16. Ekelund, K., P. Skinhoj, J. Madsen, and H. B. Konradsen. 2005. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin. Microbiol. Infect. 11:569-576.
17. Ekelund, K., P. Skinhoj, J. Madsen, and H. B. Konradsen. 2005. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J. Clin. Microbiol. 43:1789-1796.
18. Eriksson, B. K., J. Andersson, S. E. Holm, and M. Norgren. 1999. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J. Infect. Dis. 180:410-418.
19. Eriksson, B. K., M. Norgren, K. McGregor, B. G. Spratt, and B. Henriques-Normark. 2003. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin. Infect. Dis. 37:1189-1193.
20. Granizo, J. J., L. Aguilar, J. Casal, R. Dal-Re, and F. Baquero. 2000. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46:959-964.
21. Green, N. M., S. Zhang, S. F. Porcella, M. J. Nagiec, K. D. Barbian, S. B. Beres, R. B. LeFebvre, and J. M. Musser. 2005. Genome sequence of a serotype M28 strain of group A streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192:760-770.
22. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect. Dis. 166:31-37.
23. Hsueh, P. R., J. J. Wu, P. J. Tsai, J. W. Liu, Y. C. Chuang, and K. T. Luh. 1998. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin. Infect. Dis. 26:584-589.
24. Hu, M. C., M. A. Walls, S. D. Stroop, M. A. Reddish, B. Beall, and J. B. Dale. 2002. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect. Immun. 70:2171-2177.
25. Jasir, A., A. Tanna, A. Efstratiou, and C. Schalen. 2001. Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden. J. Clin. Microbiol. 39:586-590.
26. Jing, H. B., B. A. Ning, H. J. Hao, Y. L. Zheng, D. Chang, W. Jiang, and Y. Q. Jiang. 2006. Epidemiological analysis of group A streptococci recovered from patients in China. J. Med. Microbiol. 55:1101-1107.
27. Johnson, D. R., E. Kaplan, J. Sramek, E. Bicova, J. Havlicek, H. Havlickova, J. Motlova, and P. Kriz. 1996. Laboratory diagnosis of group A streptococcal infections. World Health Organization. Geneva, Switzerland.
28. Johnson, D. R., E. L. Kaplan, A. VanGheem, R. R. Facklam, and B. Beall. 2006. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55:157-164.
29. Jones, M. E., J. A. Karlowsky, D. C. Draghi, C. Thornsberry, D. F. Sahm, and D. Nathwani. 2003. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int. J. Antimicrob. Agents 22:406-419.
30. Laupland, K. B., T. Ross, D. L. Church, and D. B. Gregson. 2006. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin. Microbiol. Infect. 12:224-230.
31. Li, Z., V. Sakota, D. Jackson, A. R. Franklin, and B. Beall. 2003. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J. Infect. Dis. 188:1587-1592.
32. Matsumoto, M., K. Sakae, M. Ohta, M. Endo, R. Okuno, S. Murayama, K. Hirasawa, R. Suzuki, J. Isobe, D. Tanaka, C. Katsukawa, A. Tamaru, M. Tomita, K. Ogata, T. Yasuoka, T. Ikebe, and H. Watanabe. 2005. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11. Int. J. Antimicrob. Agents 25:142-147.
33. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
34. Nielsen, H. U., A. M. Hammerum, K. Ekelund, D. Bang, L. V. Pallesen, and N. Frimodt-Moller. 2004. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb. Drug Resist. 10:231-238.
35. Nielsen, H. U., H. J. Kolmos, and N. Frimodt-Moller. 2002. Beta-hemolytic streptococcal bacteremia: a review of 241 cases. Scand. J. Infect. Dis. 34:483-486.
36. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Farley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
37. Passaro, D. J., D. S. Smitht, E. C. Hett, A. L. Reingold, P. Daily, C. A. van Beneden, and D. J. Vugia. 2002. Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiol. Infect 129:471-478.
38. Pires, R., D. Rolo, L. Gama-Norton, A. Morais, L. Lito, M. J. Salgado, C. Johansson, G. Mollerberg, B. Henriques-Normark, J. Goncalo-Marques, and I. Santos-Sanches. 2005. Group A streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002. Microb. Drug Resist. 11:360-370.
39. Podbielski, A., B. Melzer, and R. Lutticken. 1991. Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci. Med. Microbiol. Immunol. 180:213-227.
40. Raymond, J., L. Schlegel, F. Garnier, and A. Bouvet. 2005. Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis. Infect. Control Hosp. Epidemiol. 26:455-461.
41. Reda, K. B., V. Kapur, D. Goela, J. G. Lamphear, J. M. Musser, and R. R. Rich. 1996. Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes. Infect. Immun. 64:1161-1165.
42. Schwartz, B., R. R. Facklam, and R. F. Breiman. 1990. Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167-1171.
43. Seppala, H., A. Nissinen, H. Jarvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M. L. Katila, T. Klaukka, et al. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
44. Seppala, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
45. Siljander, T., M. Toropainen, A. Muotiala, N. P. Hoe, J. M. Musser, and J. Vuopio-Varkila. 2006. emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J. Med. Microbiol. 55:1701-1706.
46. Smith, A., T. L. Lamagni, I. Oliver, A. Efstratiou, R. C. George, and J. M. Stuart. 2005. Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect. Dis. 5:494-500.
47. Sriskandan, S., L. Faulkner, and P. Hopkins. 2007. Streptococcus pyogenes: insight into the function of the streptococcal superantigens. Int. J. Biochem. Cell. Biol. 39:12-19.
48. Stalhammar-Carlemalm, M., T. Areschoug, C. Larsson, and G. Lindahl. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219.
49. Statens Serum Institut, Danish Veterinary and Food Administration, Danish Medicines Agency, and Danish Institute for Food and Veterinary Research. 2004. DANMAP 2003 - use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Statens Serum Institut, Copenhagen, Denmark.
50. Stevens, D. L. 1996. Invasive group A streptococcal disease. Infect. Agents Dis. 5:157-166.
51. Stevens, D. L., M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
52. Stromberg, A., V. Romanus, and L. G. Burman. 1991. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J. Infect. Dis. 164:595-598.
53. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
54. Svensson, N., S. Oberg, B. Henriques, S. Holm, G. Kallenius, V. Romanus, and J. Giesecke. 2000. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand. J. Infect. Dis. 32:609-614.
55. Talkington, D. F., B. Schwartz, C. M. Black, J. K. Todd, J. Elliott, R. F. Breiman, and R. R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61:3369-3374.
56. Vlaminckx, B. J., W. van Pelt, L. M. Schouls, A. van Silfhout, E. M. Mascini, C. P. Elzenaar, T. Fernandes, A. Bosman, and J. F. Schellekens. 2005. Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin. Microbiol. Infect. 11:226-231.
57. Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 269:390-391.
58. Zhang, S., N. M. Green, I. Sitkiewicz, R. B. Lefebvre, and J. M. Musser. 2006. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect. Immun. 74:4200-4213.
59. Zimbelman, J., A. Palmer, and J. Todd. 1999. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr. Infect. Dis. J. 18:1096-1100.
60. Zurawski, C. A., M. Bardsley, B. Beall, J. A. Elliott, R. Facklam, B. Schwartz, and M. M. Farley. 1998. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin. Infect. Dis. 27:150-157.